BioCentury
ARTICLE | Company News

GPC in oncology deal with Altana

January 17, 2001 8:00 AM UTC

GPC Biotech (NMarkt:GPC) closed a five-year oncology deal with Altana (FSE:ALT) subsidiary Byk Gulden pharmaceuticals group (Constance, Germany). GPC will use its functional genomics platform to ident...